GOLETA, California—Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that its Board of Directors has appointed Kevin Smith as Inogen’s president and chief executive officer and a member of the Board of Directors, effective immediately, succeeding Nabil Shabshab.
Smith brings more than 20 years of commercial leadership experience in the medical device industry, including respiratory care and durable medical equipment businesses, and a history of success in executing value-creating transformations across organizations. He most recently served as chief executive officer at Sirtex Medical Limited, a global manufacturer of interventional treatment solutions, where he implemented a growth strategy, including global expansion, and oversaw the company’s business development strategy. Smith previously held senior positions at Sensium Healthcare Ltd., Teleflex, Hillrom Holdings and ZOLL Medical Corporation. Throughout his career, he has developed extensive expertise, navigating enterprises through market cycles, leading business turnarounds, optimizing business channels, introducing new products and driving growth and international market expansion.
“Inogen is a global leader in portable oxygen therapy solutions, with a large and growing market, and leading patient-centric product portfolio,” said Elizabeth Mora, chairperson of the board. “We believe we have tremendous opportunities to scale our business, drive operational efficiencies and accelerate our growth trajectory, and the Board believes it is the right time for new leadership to improve performance and support Inogen’s next phase of its journey. With deep global medical device experience and a strong track record of successful business transformations, we believe Kevin is the right leader to capitalize on Inogen’s potential. We look forward to benefitting from his expertise as we seek to advance our commercial strategy, win new customers, and drive sustainable, long-term value for our shareholders.”
“I am honored to join Inogen, a company with a strong brand, global reach and purpose-led vision," Smith said. "I believe Inogen has a solid foundation, with leading products and significant potential to make innovative respiratory solutions the standard of care to improve patient health. I look forward to working with the board and entire team to drive growth, innovation and enhanced performance to create value for patients and our shareholders alike.”
“On behalf of the Board, I want to thank Nabil for his service and contributions to Inogen," Mora said. "Nabil has helped navigate Inogen through headwinds over the past few years, and we wish him well in his future endeavors.”
The Company reaffirms its full-year financial guidance previously announced on Nov. 7.
In light of the transition, the company will no longer attend the Stifel 2023 Healthcare Conference and the Piper Sandler 35th Annual Healthcare Conference which will take place later this month.
